Hybrid Theranostic Platforms for Cancer Nanomedical Treatment
Cancer is a leading case of mortality worldwide. Governments spent multibillion expenses on treatment and palliative care of diseased people. Despite these generous funding and intensive research with aim to find a cure or efficient treatment for cancer, until now there is a lack in selective cancer...
Main Author: | Julfakyan, Khachatur |
---|---|
Other Authors: | Khashab, Niveen M. |
Language: | en |
Published: |
2015
|
Subjects: | |
Online Access: | Julfakyan, K. (2015). Hybrid Theranostic Platforms for Cancer Nanomedical Treatment. KAUST Research Repository. https://doi.org/10.25781/KAUST-ES9R9 http://hdl.handle.net/10754/582476 |
Similar Items
-
Cyclodextrin-Based Magnetic Nanoparticles for Cancer Therapy
by: Radosław Mrówczyński, et al.
Published: (2018-03-01) -
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
by: Jörgen Elgqvist
Published: (2017-05-01) -
Gold Nanoparticles in Cancer Theranostics
by: Qinyue Gao, et al.
Published: (2021-04-01) -
Trends towards Biomimicry in Theranostics
by: Michael Evangelopoulos, et al.
Published: (2018-08-01) -
Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
by: Yuqiang Mao, et al.
Published: (2020-04-01)